Allergan Inc. (AGN): Today's Featured Health Care Loser

Allergan (AGN) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 0.4%. By the end of trading, Allergan fell $1.16 (-1.3%) to $89.59 on light volume. Throughout the day, one million shares of Allergan exchanged hands as compared to its average daily volume of 1.6 million shares. The stock ranged in price between $89.51-$90.68 after having opened the day at $90.39 as compared to the previous trading day's close of $90.75. Other company's within the Health Care sector that declined today were: Allos Therapeutics (ALTH), down 20.1%, IsoRay (ISR), down 16.3%, D Medical Industries (DMED), down 13%, and Sunshine Heart (SSH), down 13%.

• ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. Allergan has a market cap of $27.13 billion and is part of the drugs industry. The company has a P/E ratio of 27.6, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 1.9% year to date as of the close of trading on Friday. Currently there are 14 analysts that rate Allergan a buy, one analyst rates it a sell, and eight rate it a hold.

TheStreet Ratings rates Allergan as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value.

• You can view the full Allergan Ratings Report.

On the positive front, Anthera Pharmaceuticals (ANTH), up 87.2%, Alnylam Pharmaceuticals (ALNY), up 53%, Par Pharmaceutical Companies (PRX), up 36.7%, and iBio (IBIO), up 31.3%, were all gainers within the health care sector with Novo Nordisk A/S (NVO) being today's featured health care sector winner.

• Use our health care section to find sector-relevant news.
• Or find some new ideas from our top rated stocks lists.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR (XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care (RXD).

• Find other investment ideas from our top rated ETFs lists.

For more information on Allergan Inc. click any of the following:

• Allergan Inc. Stock Price

• Allergan Inc. Analyst Ratings

• Allergan Inc. Key Stats & Profile

• Allergan Inc. Earnings

• Allergan Inc. Ratio Comparison

• Allergan Inc. Growth Rates

• Allergan Inc. Balance Sheet

• Allergan Inc. Cash Flow

• Allergan Inc. Income Statement